Optogenics researchers win a Nobel Prize; Roche bets on Alector brain drug

The Nobel laureates laid the foundation for a new field of brain research, the award committee wrote. Elsewhere, Roche and CSL cut licensing deals and the FDA endorsed broader use of a Lilly medicine.